These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11100335)

  • 21. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's esophagus: can biomarkers predict progression to malignancy?
    Tischoff I; Tannapfel A
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):653-63. PubMed ID: 19072343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.
    Woerner SM; Kloor M; Mueller A; Rueschoff J; Friedrichs N; Buettner R; Buzello M; Kienle P; Knaebel HP; Kunstmann E; Pagenstecher C; Schackert HK; Möslein G; Vogelsang H; von Knebel Doeberitz M; Gebert JF;
    Oncogene; 2005 Apr; 24(15):2525-35. PubMed ID: 15735733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues.
    Dvorakova K; Payne CM; Ramsey L; Bernstein H; Holubec H; Chavarria M; Bernstein C; Sampliner RE; Riley C; Prasad A; Garewal H
    Am J Gastroenterol; 2005 Feb; 100(2):424-31. PubMed ID: 15667503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinogenesis: from epidemiology to molecular biology].
    Tubiana M
    Bull Acad Natl Med; 1998; 182(1):19-29; discussion 29-31. PubMed ID: 9622929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
    Sanz-Ortega J; Hernández S; Saez MC; Sierra E; Sanz-Ortega G; Torres A; Balibrea JL; Sanz-Esponera J; Merino MJ
    Hepatogastroenterology; 2003; 50(50):404-7. PubMed ID: 12749233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic ablation of a candidate tumor suppressor gene, Rest, does not promote mouse colon carcinogenesis.
    Hatano Y; Yamada Y; Hata K; Phutthaphadoong S; Aoki H; Hara A
    Cancer Sci; 2011 Sep; 102(9):1659-64. PubMed ID: 21668584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic alterations and metabolic polymorphisms.
    Freedman AN
    IARC Sci Publ; 1999; (148):37-50. PubMed ID: 10493247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis.
    Arnold CN; Goel A; Blum HE; Boland CR
    Cancer; 2005 Nov; 104(10):2035-47. PubMed ID: 16206296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary colorectal cancer syndromes.
    Guanti G; Bukvić N
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):23-5. PubMed ID: 11432238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
    Brabletz T; Jung A; Dag S; Reu S; Kirchner T
    Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.